|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 469.55 USD | +1.15% |
|
-1.97% | +16.60% |
| 07-15 | Vertex Pharmaceuticals Incorporated Presents at American Diabetes Association 85th Scientific Sessions, Jun-20-2025 07:15 PM | |
| 07-15 | Risk On Recharged |  |
| Capitalization | 121B 103B 96.13B 89.6B 165B 10,348B 184B 1,166B 439B 4,853B 452B 443B 17,772B | P/E ratio 2025 * |
31.3x | P/E ratio 2026 * | 26.9x |
|---|---|---|---|---|---|
| Enterprise value | 111B 95.31B 88.71B 82.68B 152B 9,548B 170B 1,076B 405B 4,478B 417B 409B 16,399B | EV / Sales 2025 * |
9.32x | EV / Sales 2026 * | 8.04x |
| Free-Float |
99.04% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Vertex Pharmaceuticals Incorporated
More recommendations
More press releases
More news
| 1 day | +1.15% | ||
| 1 week | -1.97% | ||
| Current month | +5.47% | ||
| 1 month | +4.13% | ||
| 3 months | -3.36% | ||
| 6 months | +12.61% | ||
| Current year | +16.60% |
| 1 week | 463.4 |  | 478.27 |
| 1 month | 436.8 | | 484.56 |
| Current year | 397.24 | | 519.68 |
| 1 year | 377.85 | | 519.88 |
| 3 years | 271.61 | | 519.88 |
| 5 years | 176.36 | | 519.88 |
| 10 years | 71.46 | | 519.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 31/03/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 09/04/2019 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 65 | 31/12/1997 |
Jeffrey Leiden
CHM | Chairman | 69 | 30/04/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 56 | 17/06/2015 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.15% | -1.97% | -3.97% | +60.34% | 119B | ||
| +2.34% | +0.37% | -16.12% | +138.18% | 693B | ||
| +6.19% | +5.44% | +9.12% | -7.55% | 373B | ||
| +2.25% | -0.02% | +12.64% | +24.06% | 329B | ||
| +0.12% | -3.63% | -55.45% | +3.60% | 299B | ||
| +0.47% | -0.58% | -0.97% | -22.80% | 255B | ||
| -0.98% | -2.65% | -4.02% | +15.13% | 235B | ||
| -0.57% | +0.71% | -13.75% | -6.07% | 218B | ||
| +1.12% | -1.53% | -34.29% | -13.20% | 205B | ||
| +2.23% | +0.84% | -10.24% | +20.24% | 157B | ||
| Average | +0.50% | -0.93% | -11.71% | +21.19% | 288.37B | |
| Weighted average by Cap. | +0.27% | -0.74% | -11.61% | +36.76% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 11.93B 10.22B 9.51B 8.87B 16.34B 1,024B 18.24B 115B 43.47B 480B 44.76B 43.83B 1,759B | 13.12B 11.24B 10.46B 9.75B 17.97B 1,126B 20.05B 127B 47.8B 528B 49.22B 48.2B 1,934B |
| Net income | 3.88B 3.33B 3.1B 2.89B 5.32B 333B 5.94B 37.58B 14.15B 156B 14.57B 14.27B 573B | 4.44B 3.8B 3.54B 3.3B 6.08B 381B 6.78B 42.92B 16.16B 179B 16.64B 16.3B 654B |
| Net Debt | -9.32B -7.98B -7.43B -6.92B -12.76B -799B -14.24B -90.11B -33.94B -375B -34.94B -34.22B -1,373B | -15.1B -12.94B -12.04B -11.22B -20.68B -1,296B -23.08B -146B -55.02B -608B -56.65B -55.48B -2,226B |
More financial data
* Estimated data
Employees
6,100
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/25 | 469.55 $ | +1.15% | 785,442 |
| 15/07/25 | 464.20 $ | -1.73% | 988,192 |
| 14/07/25 | 472.35 $ | +0.75% | 730,162 |
| 11/07/25 | 468.85 $ | -2.23% | 892,841 |
| 10/07/25 | 479.53 $ | +0.12% | 932,755 |
Delayed Quote Nasdaq, July 16, 2025 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
469.55USD
Average target price
500.23USD
Spread / Average Target
+6.53%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition